Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rudwaleit

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|November 10, 2012
ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohortRosaline van den Berg, Manouk de Hooge, Martin Rudwaleit, et al.
Seminars in Arthritis and Rheumatism|November 1, 2015
Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
RMD Open|September 24, 2025
Longitudinal association of early axial spondyloarthritis status at the time of diagnosis with disease activity over time: 10-year results from the GESPIC cohortDavid Kiefer, Imke Redeker, Murat Torgutalp, et al.
Arthritis and Rheumatism|October 31, 2009
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitisHeiner Appel, Gisela Ruiz-Heiland, Joachim Listing, et al.
Rheumatology (Oxford, England)|August 21, 2014
Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trialIn-Ho Song, Anja Weiß, Kay-Geert A Hermann, et al.
ACR Open Rheumatology|June 23, 2022
Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd StudyPhilip C Robinson, Walter P Maksymowych, Lianne S Gensler, et al.
RMD Open|June 30, 2021
Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysisBerthold Hoppe, Christian Schwedler, Hildrun Haibel, et al.
Rheumatology (Oxford, England)|July 15, 2016
Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristicsJoachim Sieper, Martin Rudwaleit, Jan Lenaerts, et al.
International Journal of Molecular Sciences|December 15, 2020
Relation of α<sub>2</sub>-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial SpondyloarthritisBerthold Hoppe, Christian Schwedler, Hildrun Haibel, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|November 10, 2012
ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohortRosaline van den Berg, Manouk de Hooge, Martin Rudwaleit, et al.
Seminars in Arthritis and Rheumatism|November 1, 2015
Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
RMD Open|September 24, 2025
Longitudinal association of early axial spondyloarthritis status at the time of diagnosis with disease activity over time: 10-year results from the GESPIC cohortDavid Kiefer, Imke Redeker, Murat Torgutalp, et al.
Arthritis and Rheumatism|October 31, 2009
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitisHeiner Appel, Gisela Ruiz-Heiland, Joachim Listing, et al.
Rheumatology (Oxford, England)|August 21, 2014
Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trialIn-Ho Song, Anja Weiß, Kay-Geert A Hermann, et al.
ACR Open Rheumatology|June 23, 2022
Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd StudyPhilip C Robinson, Walter P Maksymowych, Lianne S Gensler, et al.
RMD Open|June 30, 2021
Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysisBerthold Hoppe, Christian Schwedler, Hildrun Haibel, et al.
Rheumatology (Oxford, England)|July 15, 2016
Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristicsJoachim Sieper, Martin Rudwaleit, Jan Lenaerts, et al.
International Journal of Molecular Sciences|December 15, 2020
Relation of α<sub>2</sub>-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial SpondyloarthritisBerthold Hoppe, Christian Schwedler, Hildrun Haibel, et al.
Pageof 15